China Approves Ocumension Therapeutics Implant for Localized Production
Ocumension Therapeutics says China's NMPA approved its fluocinolone acetonide intravitreal implant for localized production.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
NMPA Approves Ocumension Implant for Localized Production
China’s NMPA approved Ocumension Therapeutics’ fluocinolone acetonide intravitreal implant for localized production.